JPRN-UMIN000018148已完成未知
The effect of Yokukansan on medication overuse headache - The effect of Yokukansan on medication overuse headache
Saitama Medical University Faculty of Medicine Department of Neurology0 个研究点目标入组 85 人开始时间: 2015年8月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 85
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •experience of taking yokukansan taking other Kampo-medicine having severe cardiac disease, liver disease, kidney disease, hematologic disorders, lung disease, or other severe disease related to life itself having psychological disorders such as depression or other disorders due to DSM-5 unable to take oral medicine under treatment of acupuncture, chiropractic, massage
研究者
相似试验
招募中
不适用
The effect of herbal prescription Yokukansan on the sleep disturbances in the elderlyinsomniaJPRN-UMIN000005461Kagawa University School of Medicine20
招募中
2 期
Efficacy and safety of Yokukansan for the treatment-resistant schizophrenia: randomized, double-blind, placebo-controlled multicenter trialTreatment-Rsistant SchizophreniaJPRN-UMIN000005018Department of Psychiatry, Shimane University School of Medicine120
已完成
2 期
Examination of effect of yokukansan in prevention of the delirium after the surgical operation.JPRN-UMIN000005423Department of surgery,yokohama city university220
未知
不适用
The safety and efficacy of Yokukansan in treating neuropsychiatric symptoms of patients with Fronto-Temporal Lobar Degeneration (FTLD)Fronto-Temporal Lobar Degeneration (FTLD)JPRN-UMIN000001897Ehime University Graduate School of Medicine20
招募中
不适用
Efficacy and Safety of Yokukansan in Schizophrenia: A Randomized, Multi-center, Double-Blind, Placebo-Controlled TrialSchizophreniaJPRN-UMIN000015709Shimane University School of Medicine60
